Keywords: savient, completes, million, sale, uk-based, rosement, pharmaceuticals
Savient completes $176 million sale of UK-based Rosement Pharmaceuticals
Article | 14 August 2006
The USA's Savient Pharmaceuticals has completed the sale of its wholly-owned UK subsidiary, Rosemont Pharmaceuticals, as part of a $176.0 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
